NBIX
Neurocrine Biosciences Inc. Healthcare - Biotechnology Investor Relations →
Neurocrine Biosciences Inc. (NBIX) closed at $141.20 as of 2026-02-02, trading 17.6% above its 200-week moving average of $120.06. The stock moved further from the line this week, up from 13.5% last week. The 14-week RSI sits at 48, indicating neutral momentum.
Over the past 1502 weeks of data, NBIX has crossed below its 200-week moving average 17 times. On average, these episodes lasted 26 weeks. The average one-year return after crossing below was -5.7%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $14.1 billion, NBIX is a large-cap stock. The company generates a free cash flow yield of 2.5%. Return on equity stands at 15.0%, a solid level. The stock trades at 4.7x book value.
Share count has increased 4.7% over three years, indicating dilution.
Over the past 28.9 years, a hypothetical investment of $100 in NBIX would have grown to $1807, compared to $1418 for the S&P 500. That represents an annualized return of 10.5% vs 9.6% for the index — confirming NBIX as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 33.7% compound annual rate, with 4 consecutive years of positive cash generation.
Growth of $100: NBIX vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After NBIX Crosses Below the Line?
Across 17 historical episodes, buying NBIX when it crossed below its 200-week moving average produced an average return of -2.3% after 12 months (median +1.0%), compared to +12.1% for the S&P 500 over the same periods. 56% of those episodes were profitable after one year. After 24 months, the average return was -18.5% vs +27.4% for the index.
Each line shows $100 invested at the moment NBIX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
NBIX has crossed below its 200-week MA 17 times with an average 1-year return of +-5.7% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 1997 | Sep 1997 | 20 | 20.7% | -2.4% | +1707.4% |
| Sep 1997 | Oct 1997 | 1 | 0.4% | -42.9% | +1367.0% |
| Oct 1997 | Nov 1999 | 106 | 51.0% | -27.6% | +1386.3% |
| Aug 2004 | Aug 2004 | 1 | 2.7% | +14.6% | +242.0% |
| Feb 2005 | Jul 2005 | 21 | 22.8% | +46.7% | +241.3% |
| Aug 2005 | Sep 2005 | 4 | 1.8% | -80.1% | +213.0% |
| Sep 2005 | Sep 2005 | 1 | 0.1% | -76.7% | +207.5% |
| May 2006 | Sep 2010 | 227 | 90.4% | -41.5% | +620.4% |
| May 2021 | May 2021 | 1 | 2.7% | -12.6% | +55.1% |
| May 2021 | Jun 2021 | 1 | 0.1% | +1.2% | +49.6% |
| Jul 2021 | Sep 2021 | 11 | 7.6% | +0.2% | +48.6% |
| Nov 2021 | Apr 2022 | 22 | 23.3% | +30.7% | +51.5% |
| Apr 2022 | Jun 2022 | 9 | 18.7% | +11.3% | +50.8% |
| Jul 2022 | Aug 2022 | 4 | 2.5% | -1.6% | +47.7% |
| Mar 2023 | Mar 2023 | 3 | 6.0% | +45.3% | +47.4% |
| May 2023 | Jul 2023 | 12 | 9.7% | +44.5% | +45.0% |
| Mar 2025 | May 2025 | 5 | 18.0% | N/A | +47.6% |
| Average | 26 | — | +-5.7% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02